Department of Endocrine (Zhao YQ, Tian DZ,Wei XH),Department of Oncology (Bao QD),Department of Radiotherapy (Cui YL),Anyang District Hospital,Puyang 455000,China;Department of Radiotherapy,Henan Province People′s Hospital,Zhengzhou 450002,China (Wu GY)
AbstractObjective To study the effect of curcumin on the radiosensitivity of the human papillary thyroid cancer cell line TPC-1, to investigate the signaling pathway probably targeted by curcumin, and to provide new insights for the development of radiosensitizers for thyroid cancer. Methods The human papillary thyroid cancer cell line TPC-1 was treated with curcumin and radioactive iodine. CCK-8 assay, colony formation assay, and flow cytometry were used to evaluate cell proliferation, colony formation ability, and cell apoptosis, respectively. Western blot was used to measure the expression of p50, p65, and apoptosis-related proteins, Bcl-2 and Bax. Cell proliferation, colony formation ability, and cell apoptosis were determined again after the activity of the NF-κB signaling pathway was blocked by a NF-κB signaling pathway inhibitor PDTC. Results After treatment with curcumin and radioactive iodine, the human papillary thyroid cancer TPC-1 cells had reduced cell proliferation and colony formation, an elevated apoptosis rate, downregulated expression of anti-apoptotic Bcl-2, and upregulated expression of pro-apoptotic Bax in a dose-dependent manner. These Results indicated that curcumin enhanced the radiosensitivity of TPC-1 cells. Curcumin inhibited the activation of the NF-κB signaling pathway in the TPC-1 cells treated with radioactive iodine. When the activity of the NF-κB pathway was blocked by PDTC, cell proliferation and colony formation were reduced and the apoptosis rate was increased, indicating an enhanced radiosensitivity of TPC-1 cells. Conclusions Curcumin is likely to target the NF-κB signaling pathway. It regulates the radiosensitivity of thyroid cancer cells by inhibiting the activity of the NF-κB signaling pathway.
Zhao Yongqiang,Tian Dezeng,Wei Xiaohua et al. Curcumin enhances the radiosensitivity of thyroid cancer cells TPC-1[J]. Chinese Journal of Radiation Oncology, 2016, 25(8): 886-890.
Zhao Yongqiang,Tian Dezeng,Wei Xiaohua et al. Curcumin enhances the radiosensitivity of thyroid cancer cells TPC-1[J]. Chinese Journal of Radiation Oncology, 2016, 25(8): 886-890.
[1] 冯辉豪,程晓明,曾峰,等.甲状腺癌的分子靶向治疗研究进展[J].临床耳鼻咽喉头颈外科杂志,2015,29(24):26 Feng HH,Cheng XM,Xiao F,et al. Advances in molecular targeted therapy of thyroid cancer[J].J Clin Ent Head Neck Surg,2015,29(24):26 [2] 陈磊,张青云,杨植,等.甲状腺未分化癌的诊治进展[J].中国现代普通外科进展,2014,17(6):494-496 Chen L,Zhang QY,Yang ZH,et al. Advances in diagnosis and treatment of undifferentiated thyroid carcinoma[J].Adv Moder Gener Surg China,2014,17(6):494-496 [3] Lv ZD,Liu XP,Zhao WJ,et al. Curcumin induces apoptosis in breast cancer cells and inhibits tumor growth in vitro and in vivo[J].Int J Clin Exp Pathol,2014,7(6):2818-2824 [4] Chen A,Xu J,Johnson A.Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through redμcing the activity of the transcription factor Egr-1[J].Oncogene,2006,25(2):278-287 [5] Liduan Z,Qiangsong T,Cuihuan W.Growth-inhibitory effects of curcumin on ovary cancer cells and its mechanisms[J].J Huazhong Univ Sci Technol[Med Sci],2004,24(1):55-58 [6] Ma J,Fang B,Zeng F,et al. Curcumin inhibits cell growth and invasion through up-regulation of miR-7 in pancreatic cancer cells[J].Toxicol Lett,2014,231(1):82-91.DOI:10.1016/j.toxlet.2014.09.014 [7] Javvadi P,Segan AT,Tuttle SW,et al. The chemopreventive agent curcumin is a potent radiosensitizer of human cervical tumor cells via increased reactive oxygen species production and overactivation of the mitogen-activated protein kinase pathway[J].Mol Pharmacol,2008,73(5):1491-1501.DOI:10.1124/mol.107.043554 [8] Sandur SK,Deorukhkar A,Pandey MK,et al. Curcumin modulates the radiosensitivity of colorectal cancer cells by suppressing constitutive and indμcible NF-κB activity[J].Int J Radiat Oncol Biol Phys,2009,75(2):534-542.DOI:10.1016/j.ijrobp.2009.06.034 [9] Orr WS,Denbo JW,Saab KR,et al. Curcumin potentiates rhabdomyosarcoma radiosensitivity by suppressing NF-κB activity[J/OL].PloS One,2013,8(2):e51309.DOI:10.1371/journal.pone.0051309 [10] Qian Y,Ma J,Guo X,et al. Curcumin enhances the radiosensitivity of u87 cells by indμcing dusp-2 up-regulation[J].Cell Phys Bioch,2015,35(4):1381-1393.DOI:10.1159/000373959 [11] Qiao Q,Jiang Y,Li G.Inhibition of the PI3K/AKT-NF-κB pathway with curcumin enhanced radiation-induced apoptosis in human Burkitt’s lymphoma[J].J Pharmacol Sci,2013,121(4):247-256 [12] Jin H,Qiao F,Wang Y,et al. Curcumin inhibits cell proliferation and induces apoptosis of human non-small cell lung cancer cells through the upregulation of miR-192-5p and suppression of PI3K/Akt signaling pathway[J].Oncol Rep,2015,34(5):2782-2789.DOI:10.3892/or.2015.4258 [13] Prakobwong S,Gupta SC,Kim JH,et al. Curcumin suppresses proliferation and induces apoptosis in human biliary cancer cells through modulation of multiple cell signaling pathways[J].Carcinogenesis,2011,32(9):1372-1380.DOI:10.1093/carcin/bgr032 [14] Guo LD,Chen XJ,Hu YH,et al. Curcumin inhibits proliferation and induces apoptosis of human colorectal cancer cells by activating the mitochondria apoptotic pathway[J].Phytother Res,2013,27(3):422-430.DOI:10.1002/ptr.4731 [15] Weir NM,Selvendiran K,Kutala VK,et al. Curcumin induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating Akt and p38 MAPK[J].Cancer Biol Ther,2007,6(2):178-184 [16] Shishodia S,Amin H M,Lai R,et al. Curcumin (diferuloylmethane) inhibits constitutive NF-κB activation,induces G1/S arrest,suppresses proliferation,and induces apoptosis in mantle cell lymphoma[J].Biochem Pharmacol,2005,70(5):700-713 [17] Song F,Zhang L,Yu HX,et al. The mechanism underlying proliferation-inhibitory and apoptosis-indμcing effects of curcumin on papillary thyroid cancer cells[J].Food Chemist,2012,132(1):43-50.DOI:10.1016/j.foodchem.2011.10.024 [18] 杨春妮,杨一兵.NF-κB及其信号传导通路与肿瘤放射耐受的研究进展[J].中国现代医药杂志,2015,17(12).106-169 Yang CHN,Yang YB.Adcances in NF-κB and its signal transduction pathway and tumor radiation tolerance[J].Chin J Moder Med,2015,17(12).106-169 [19] Magné N,Toillon RA,Bottero V,et al. NF-κB modulation and ionizing radiation:mechanisms and future directions for cancer treatment[J].Cancer Lett,2006,231(2):158-168 [20] Didelot C,Barberi-Heyob M,Bianchi A,et al. Constitutive NF-κB activity influences basal apoptosis and radiosensitivity of head-and-neck carcinoma cell lines[J].Int J Radiat Oncol Biol Phys,2001,51(5):1354-1360 [21] Kozakai N,Kikuchi E,Hasegawa M,et al. Enhancement of radiosensitivity by a unique novel NF-κB inhibitor,DHMEQ,in prostate cancer[J].Br J Cancer,2012,107(4):652-657.DOI:10.1038/bjc.2012.321 [23] Russo SM,Tepper JE,Baldwin AS,et al. Enhancement of radiosensitivity by proteasome inhibition:implications for a role of NF-κB[J].Int J Radiat Oncol Biol Phys,2001,50(1):183-193 [23] 王媛,惠双.沙利度胺对人结肠癌小鼠移植瘤放射敏感性的影响及其机制[J].中国老年学杂志,2015,35(13):3544-3545 Wang Y,Hui SH.Thalidomide effect of colon cancer in mice transplanted tumor radiosensitivity of human and its mechanism[J].Chin J Gerontol,2015,35(13):3544-3545 [24] Starenki DV,Namba H,Saenko VA,et al. Modulation of radiosensitivity of thyroid cancer cells by inhibition of NF-κB signaling[C].Int Cong Ser,2003:147-155
2016, Vol. 25 
